Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

T Abshire, J Cox-Gill, C L Kempton, F W G Leebeek, M Carcao, P Kouides, S Donfield, Erik Berntorp

Research output: Contribution to journalArticlepeer-review

Abstract

Treatment of mucosal bleeding (epistaxis, gastrointestinal and menorrhagia) and joint bleeding remains problematic in clinically severe von Willebrand Disease (VWD). Patients are often unresponsive to treatment (e.g. desmopressin or antifibrinolytic therapy) and may require von Willebrand (VW) factor replacement therapy. There are little data on the use of prophylaxis in VWD and none applied in a prospective, treatment escalation design.
Original languageEnglish
Pages (from-to)1585-1589
JournalJournal of Thrombosis and Haemostasis
Volume13
Issue number9
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems

Fingerprint

Dive into the research topics of 'Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.'. Together they form a unique fingerprint.

Cite this